SE462895B - Transdermal farmaceutisk komposition bestaaende av ett kolinergt eller antikolinergt medel och en laagmolekylaer fettsyra samt ett foerband eller en kompress innehaallande kompositionen - Google Patents
Transdermal farmaceutisk komposition bestaaende av ett kolinergt eller antikolinergt medel och en laagmolekylaer fettsyra samt ett foerband eller en kompress innehaallande kompositionenInfo
- Publication number
- SE462895B SE462895B SE8503664A SE8503664A SE462895B SE 462895 B SE462895 B SE 462895B SE 8503664 A SE8503664 A SE 8503664A SE 8503664 A SE8503664 A SE 8503664A SE 462895 B SE462895 B SE 462895B
- Authority
- SE
- Sweden
- Prior art keywords
- cholinergic
- dressing
- fatty acid
- compress
- skin
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Dermatology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL72684A IL72684A (en) | 1984-08-14 | 1984-08-14 | Pharmaceutical compositions for controlled transdermal delivery of cholinergic or anticholinergic basic drugs |
Publications (3)
Publication Number | Publication Date |
---|---|
SE8503664D0 SE8503664D0 (sv) | 1985-08-01 |
SE8503664L SE8503664L (sv) | 1986-02-15 |
SE462895B true SE462895B (sv) | 1990-09-17 |
Family
ID=11055266
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE8503664A SE462895B (sv) | 1984-08-14 | 1985-08-01 | Transdermal farmaceutisk komposition bestaaende av ett kolinergt eller antikolinergt medel och en laagmolekylaer fettsyra samt ett foerband eller en kompress innehaallande kompositionen |
Country Status (12)
Country | Link |
---|---|
US (1) | US4788063A (fr) |
JP (1) | JPS61186317A (fr) |
CA (1) | CA1260829A (fr) |
CH (1) | CH667393A5 (fr) |
DE (1) | DE3528979A1 (fr) |
DK (1) | DK168585B1 (fr) |
FR (1) | FR2569112B1 (fr) |
GB (1) | GB2163347B (fr) |
IL (1) | IL72684A (fr) |
IT (1) | IT1221024B (fr) |
NO (1) | NO173486C (fr) |
SE (1) | SE462895B (fr) |
Families Citing this family (71)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4680172A (en) * | 1985-03-05 | 1987-07-14 | Ciba-Geigy Corporation | Devices and methods for treating memory impairment |
US4765985A (en) * | 1985-03-05 | 1988-08-23 | Ciba-Geigy Corporation | Devices and methods for treating memory impairment |
US4855290A (en) | 1985-05-10 | 1989-08-08 | State Of Israel, Represented By Prime Minister's Office, Israel Institute For Biological Research | Derivatives of quinuclidine |
US4666926A (en) * | 1986-02-27 | 1987-05-19 | Warner-Lambert Company | Transdermal formulations |
US4908027A (en) * | 1986-09-12 | 1990-03-13 | Alza Corporation | Subsaturated transdermal therapeutic system having improved release characteristics |
US4861800A (en) * | 1987-08-18 | 1989-08-29 | Buyske Donald A | Method for administering the drug deprenyl so as to minimize the danger of side effects |
DE3729299A1 (de) * | 1987-09-02 | 1989-03-23 | Beiersdorf Ag | Transdermales therapeutisches system |
US6107499A (en) * | 1988-02-26 | 2000-08-22 | Neuromedica, Inc. | Dopamine analog amide |
US5994392A (en) | 1988-02-26 | 1999-11-30 | Neuromedica, Inc. | Antipsychotic prodrugs comprising an antipsychotic agent coupled to an unsaturated fatty acid |
GB8807504D0 (en) * | 1988-03-29 | 1988-05-05 | Sandoz Ltd | Improvements in/relating to organic compounds |
US5075314A (en) * | 1988-10-27 | 1991-12-24 | Leitman Esther M | Antimicturition composition and novel method |
US5075312A (en) * | 1988-10-27 | 1991-12-24 | Leitman Esther M | Novel anti-micturition composition and method |
DE3843239C1 (fr) | 1988-12-22 | 1990-02-22 | Lohmann Therapie Syst Lts | |
DE3843238C1 (fr) * | 1988-12-22 | 1990-02-22 | Lohmann Therapie Syst Lts | |
CA2012192A1 (fr) * | 1989-03-28 | 1990-09-28 | Munir A. Hussain | Administration intranasale de physostigmine et d'arecoline |
NZ237241A (en) * | 1990-03-02 | 1993-11-25 | Pharmetrix Corp | Method for increasing the storage stability of physostigmine |
WO1991015176A1 (fr) * | 1990-04-06 | 1991-10-17 | Pharmetrix Corporation | Dispositif et procede d'administration amelioree de physostigmine |
US5931774A (en) * | 1991-06-14 | 1999-08-03 | Proxima Therapeutics, Inc. | Inflatable devices for tumor treatment |
US5429582A (en) * | 1991-06-14 | 1995-07-04 | Williams; Jeffery A. | Tumor treatment |
GB9118028D0 (en) * | 1991-08-21 | 1991-10-09 | Secr Defence Brit | Improved transdrmal formulations |
TW224048B (fr) * | 1992-03-30 | 1994-05-21 | Hoechst Roussel Pharma | |
US5596007A (en) * | 1992-05-18 | 1997-01-21 | Pharmaco Behavioral Associates, Inc. | Therapeutic method to alleviate the craving associated with cessation of tobacco with cotinine |
US5643928A (en) * | 1992-10-21 | 1997-07-01 | Pharmaco Behavioral Associates, Inc. | Human body weight management |
US5612357A (en) * | 1992-05-18 | 1997-03-18 | Pharmaco Behavioral Associates, Inc. | Use of cotinine to assist in the cessation of tobacco smoking |
US5869505A (en) * | 1993-02-02 | 1999-02-09 | Keenan; Robert M. | Nicotine metabolites and nicotine dependence |
DE4238223C1 (de) * | 1992-11-12 | 1994-05-26 | Lohmann Therapie Syst Lts | Transdermales therapeutisches System zur Verabreichung von Physostigmin an die Haut und Verfahren zu dessen Herstellung |
US5573774A (en) * | 1993-02-02 | 1996-11-12 | Keenan; Robert M. | Nicotine metabolites, nicotine dependence and human body weight |
DE4313928C2 (de) * | 1993-04-28 | 1996-09-19 | Lohmann Therapie Syst Lts | Transdermales therapeutisches System zur kontrollierten Abgabe von Pilocarpin an die Haut, Verfahren zu seiner Herstellung und seine Verwendung |
DE4342174C1 (de) * | 1993-12-10 | 1995-05-11 | Lohmann Therapie Syst Lts | Transdermales therapeutisches System sowie ein Verfahren zur Herstellung eines transdermalen therapeutischen Systems zur kombinierten transdermalen Anwendung von Physostigmin und Scopolamin für die Prophylaxe und zur Vorbehandlung einer Vergiftung durch hochtoxische phosphororganische Nervengifte, insbesondere Soman und seine Verwendung |
JP3908795B2 (ja) * | 1994-11-29 | 2007-04-25 | 久光製薬株式会社 | ケトチフェン含有経皮投与製剤 |
US5861431A (en) * | 1995-06-07 | 1999-01-19 | Iotek, Inc. | Incontinence treatment |
DE19533089C1 (de) * | 1995-09-07 | 1997-05-22 | Hexal Ag | Tacrin-Pflaster |
US5795909A (en) | 1996-05-22 | 1998-08-18 | Neuromedica, Inc. | DHA-pharmaceutical agent conjugates of taxanes |
US6576636B2 (en) | 1996-05-22 | 2003-06-10 | Protarga, Inc. | Method of treating a liver disorder with fatty acid-antiviral agent conjugates |
US6479074B2 (en) | 1996-10-24 | 2002-11-12 | Pharmaceutical Applications Associates Llc | Methods and transdermal compositions for pain relief |
US6572880B2 (en) | 1996-10-24 | 2003-06-03 | Pharmaceutical Applications Associates Llc | Methods and transdermal compositions for pain relief |
US6290986B1 (en) | 1996-10-24 | 2001-09-18 | Pharmaceutical Applications Associates, Llc | Method and composition for transdermal administration of pharmacologic agents |
US5977174A (en) * | 1997-11-26 | 1999-11-02 | Neuromedica, Inc. | Cholinergic compositions and uses thereof |
US6197764B1 (en) | 1997-11-26 | 2001-03-06 | Protarga, Inc. | Clozapine compositions and uses thereof |
US6146656A (en) * | 1998-01-22 | 2000-11-14 | Nitto Denko Corporation | Percutaneous absorption preparation |
US6225444B1 (en) | 1998-02-10 | 2001-05-01 | Protarga, Inc. | Neuroprotective peptides and uses thereof |
JP3987655B2 (ja) * | 1998-03-03 | 2007-10-10 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | 抗痴呆薬を含有した経皮適用製剤又は坐剤 |
US7235583B1 (en) | 1999-03-09 | 2007-06-26 | Luitpold Pharmaceuticals, Inc., | Fatty acid-anticancer conjugates and uses thereof |
CN1384825A (zh) | 1999-08-31 | 2002-12-11 | 马克西亚药品公司 | 亚苄基-噻唑烷二酮及其类似物以及它们在治疗糖尿病中的应用 |
US7077859B2 (en) | 2000-12-22 | 2006-07-18 | Avantec Vascular Corporation | Apparatus and methods for variably controlled substance delivery from implanted prostheses |
IL157740A0 (en) | 2001-03-07 | 2004-03-28 | Incyte San Diego Inc | Heterocyclic derivatives and pharmaceutical compositions containing the same |
JP2004523571A (ja) * | 2001-03-08 | 2004-08-05 | マキシア・ファーマシューティカルズ・インコーポレイテッド | Rxr活性化分子 |
CA2340824A1 (fr) * | 2001-03-14 | 2002-09-14 | Ibm Canada Limited-Ibm Canada Limitee | Methode et systeme pour l'analyse du comportement des applications |
JP2005500988A (ja) * | 2001-03-23 | 2005-01-13 | ルイトポルド・ファーマシューティカルズ・インコーポレーテッド | 脂肪族アミン薬物複合体 |
JP4634694B2 (ja) | 2001-03-23 | 2011-02-16 | ルイトポルド・ファーマシューティカルズ・インコーポレーテッド | 脂肪アルコール薬物複合体 |
WO2003016267A1 (fr) * | 2001-08-17 | 2003-02-27 | Incyte San Diego Incorporated | Derives d'oxime pour le traitement de la dyslipidemie et de l'hypercholesterolemie |
WO2003028723A1 (fr) * | 2001-09-27 | 2003-04-10 | Saitama Daiichi Pharmaceutical Co., Ltd. | Compositions pharmaceutiques destinee a l'absorption par voie percutanee contenant des derives d'imidazopyridine fondus |
EP1456187A4 (fr) * | 2001-11-15 | 2005-02-09 | Incyte San Diego Inc | Heterocycles n-substitues pour le traitement de l'hypercholesterolemie, de la dyslipidemie et autres troubles du metabolisme, du cancer et de pathologies diverses |
US8529807B2 (en) | 2002-01-17 | 2013-09-10 | Lts Lohmann Therapie-Systeme Ag | Method for neutralizing or recycling carrier materials for film-like coatings |
US7102000B2 (en) * | 2002-03-08 | 2006-09-05 | Incyte San Diego Inc. | Heterocyclic amide derivatives for the treatment of diabetes and other diseases |
US7196108B2 (en) * | 2002-03-08 | 2007-03-27 | Incyte San Diego Inc. | Bicyclic heterocycles for the treatment of diabetes and other diseases |
US20040087576A1 (en) * | 2002-11-05 | 2004-05-06 | Haracz John L. | Antimnemonic therapy for hypermemory syndromes |
WO2004066952A2 (fr) * | 2003-01-29 | 2004-08-12 | Incyte Corporation | Derives du benzoxazole, du benzothiazole et du benzimidazole destines a traiter le cancer et d'autres maladies |
BRPI0409501A (pt) * | 2003-04-18 | 2006-04-18 | Incyte San Diego Inc | compostos isocromanos substituìdos para o tratamento de desordens metabólicas, de cáncer e de outras doenças |
DE10338174A1 (de) | 2003-08-20 | 2005-03-24 | Lts Lohmann Therapie-Systeme Ag | Transdermale Arzneimittelzubereitungen mit Wirkstoffkombinationen zur Behandlung der Parkinson-Krankheit |
TWI372066B (en) | 2003-10-01 | 2012-09-11 | Wyeth Corp | Pantoprazole multiparticulate formulations |
US20050182044A1 (en) * | 2004-02-17 | 2005-08-18 | Bruinsma Gosse B. | Combinatorial therapy with an acetylcholinesterase inhibitor and (3aR)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3,-b]indol-5-yl phenylcarbamate |
CA2508585A1 (fr) * | 2004-06-01 | 2005-12-01 | Axonyx, Inc. | Dispositif d'administration transdermique pour le traitement des troubles cognitifs |
US20050272804A1 (en) * | 2004-06-08 | 2005-12-08 | Axonyx, Inc | Methods of delaying Alzheimer's disease progression using a beta-amyloid precursor protein inhibitor and a HMG CoA reductase inhibitor |
JP2008519847A (ja) * | 2004-11-10 | 2008-06-12 | ザ トラスティーズ オブ コロンビア ユニヴァーシティ イン ザ シティ オブ ニューヨーク | 運動障害の治療方法 |
JP2007308403A (ja) * | 2006-05-17 | 2007-11-29 | Kenji Yoshida | 皮膚外用剤 |
US20070287727A1 (en) * | 2006-06-08 | 2007-12-13 | Jacob Hiller | Anti-Nicotine Treatment |
WO2009142968A2 (fr) * | 2008-05-20 | 2009-11-26 | Olema Pharmaceuticals, Inc. | Sels de l'acide valproïque |
WO2010048572A1 (fr) | 2008-10-23 | 2010-04-29 | Cornell University | Nouveau procédé antiviral |
LT2968992T (lt) | 2013-03-15 | 2020-03-25 | Tonix Pharma Holdings Limited | Ciklobenzaprino hidrochlorido ir manitolio eutektinės kompozicijos |
SG11202004799TA (en) | 2017-12-11 | 2020-06-29 | Tonix Pharma Holdings Ltd | Cyclobenzaprine treatment for agitation, psychosis and cognitive decline in dementia and neurodegenerative conditions |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE521851A (fr) * | ||||
GB469526A (en) * | 1936-10-02 | 1937-07-27 | Earl Barger Putt | Acetyl-salicylic acid composition |
AR207805A1 (es) * | 1975-02-06 | 1976-10-29 | Alza Corp | Substrato apropiado para formar apositos para la dispensacion continua de escopolamina base por via transdermica |
FR2427100A1 (fr) * | 1978-06-02 | 1979-12-28 | Kali Chemie Pharma Gmbh | Composition pharmaceutique a propriete de resorption amelioree et procede pour sa fabrication |
GB2051574B (en) * | 1979-05-10 | 1984-01-18 | Kyoto Pharma Ind | Adjuvant for promoting absorption of pharmacologically active substances through the rectum |
US4286592A (en) * | 1980-02-04 | 1981-09-01 | Alza Corporation | Therapeutic system for administering drugs to the skin |
NL8104929A (nl) * | 1980-11-12 | 1982-06-01 | Alza Corp | Anticholinergische preparaten, alsmede de bereiding en de toepassing ervan. |
GB2105990B (en) * | 1981-08-27 | 1985-06-19 | Nitto Electric Ind Co | Adhesive skin patches |
DE3204551A1 (de) * | 1982-02-10 | 1983-08-18 | Boehringer Ingelheim KG, 6507 Ingelheim | Verfahren zur herstellung einer pharmazeutischen zubereitung in form eines polyacrylat-films |
JPS58172312A (ja) * | 1982-04-02 | 1983-10-11 | Toa Eiyou Kagaku Kogyo Kk | ニフエジピン外用剤 |
EP0127426A1 (fr) * | 1983-05-23 | 1984-12-05 | Takeda Chemical Industries, Ltd. | Compositions pharmaceutiques percutanées pour application externe |
JPS59216825A (ja) * | 1983-05-23 | 1984-12-06 | Takeda Chem Ind Ltd | 経皮吸収外用製剤 |
JPS60199834A (ja) * | 1984-03-23 | 1985-10-09 | Takeda Chem Ind Ltd | 経皮吸収外用製剤 |
DK243084A (da) * | 1983-05-26 | 1984-11-27 | Takeda Chemical Industries Ltd | Perkutane farmaceutiske praeparater til udvortes brug |
US4568343A (en) * | 1984-10-09 | 1986-02-04 | Alza Corporation | Skin permeation enhancer compositions |
-
1984
- 1984-08-14 IL IL72684A patent/IL72684A/xx not_active IP Right Cessation
-
1985
- 1985-04-09 JP JP60075226A patent/JPS61186317A/ja active Pending
- 1985-07-30 US US06/760,609 patent/US4788063A/en not_active Expired - Fee Related
- 1985-07-31 CA CA000487829A patent/CA1260829A/fr not_active Expired
- 1985-08-01 SE SE8503664A patent/SE462895B/sv not_active IP Right Cessation
- 1985-08-02 GB GB08519530A patent/GB2163347B/en not_active Expired
- 1985-08-05 DK DK354985A patent/DK168585B1/da active
- 1985-08-08 CH CH3404/85A patent/CH667393A5/de not_active IP Right Cessation
- 1985-08-12 IT IT21922/85A patent/IT1221024B/it active
- 1985-08-13 NO NO853195A patent/NO173486C/no unknown
- 1985-08-13 DE DE19853528979 patent/DE3528979A1/de active Granted
- 1985-08-14 FR FR8512416A patent/FR2569112B1/fr not_active Expired
Also Published As
Publication number | Publication date |
---|---|
JPS61186317A (ja) | 1986-08-20 |
GB8519530D0 (en) | 1985-09-11 |
SE8503664D0 (sv) | 1985-08-01 |
US4788063A (en) | 1988-11-29 |
IL72684A0 (en) | 1984-11-30 |
IT1221024B (it) | 1990-06-21 |
IT8521922A0 (it) | 1985-08-12 |
SE8503664L (sv) | 1986-02-15 |
DK168585B1 (da) | 1994-05-02 |
FR2569112B1 (fr) | 1988-10-07 |
DK354985D0 (da) | 1985-08-05 |
NO173486B (no) | 1993-09-13 |
GB2163347B (en) | 1989-01-25 |
DE3528979C2 (fr) | 1989-12-07 |
CA1260829A (fr) | 1989-09-26 |
IL72684A (en) | 1989-02-28 |
NO173486C (no) | 1993-12-22 |
DK354985A (da) | 1986-02-15 |
NO853195L (no) | 1986-02-17 |
CH667393A5 (de) | 1988-10-14 |
FR2569112A1 (fr) | 1986-02-21 |
DE3528979A1 (de) | 1986-02-27 |
GB2163347A (en) | 1986-02-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE462895B (sv) | Transdermal farmaceutisk komposition bestaaende av ett kolinergt eller antikolinergt medel och en laagmolekylaer fettsyra samt ett foerband eller en kompress innehaallande kompositionen | |
AU630088B2 (en) | Deprenyl for systemic transdermal administration | |
US5593686A (en) | Pharmaceutical compositions | |
Pert et al. | Localization of the antinociceptive action of morphine in primate brain | |
KR19990028787A (ko) | 펜타닐 함유 경피 투여 테이프 제제 | |
AU709379B2 (en) | Transdermal formulation | |
EP0315218B1 (fr) | Composition pharmaceutique | |
AU2001295512B2 (en) | Combination of a transdermal therapeutic system and an oral and/or parenteral preparation containing dopamine agonists for the treatment of dopaminergic disease states | |
EP0727208B1 (fr) | Formulation transdermale d'un composé à activité muscarinique | |
US4777047A (en) | Transdermal application form of calcium antagonists | |
EP0517840A1 (fr) | Procede et dispositif d'administration de physostigmine | |
CN111346073B (zh) | 一种透皮给药的药物组合物及其制备方法和应用 | |
US5605701A (en) | Transdermal formulation | |
US10376474B2 (en) | Fentanyl-containing patch for external use | |
KR20070059079A (ko) | 경피 페로스피론 투여용 의약적 조성물 | |
PL175077B1 (pl) | Przezskórny układ terapeutyczny do leczenia jaskry oraz sposób otrzymywania przezskórnego układu terapeutycznego do leczenia jaskry | |
JPS62148422A (ja) | 治療システム | |
JPH0648962A (ja) | 経皮吸収製剤用組成物 | |
JP2843923B2 (ja) | 経皮吸収組成物 | |
JP6978417B2 (ja) | プラミペキソール経皮送達系及びその使用 | |
EP0315217A2 (fr) | Composition pharmaceutique | |
MXPA97006143A (en) | Transderm formulation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NAL | Patent in force |
Ref document number: 8503664-8 Format of ref document f/p: F |
|
NUG | Patent has lapsed |
Ref document number: 8503664-8 Format of ref document f/p: F |